Related Articles
Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients
Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.
Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases
Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients